SMMT rated Speculative Hold. Binary FDA bet on ivonescimab — bull case $28-35, bear case $3-5. PDUFA Nov 14, 2026.
Related To: Healthcare Stocks

TMO rated Buy with $575 target (+22%). Forward P/E 17.5x cheapest since March 2020. $6.3B FCF, Life Sciences recovery, RSI deeply oversold at 28.
Prev
1


